Menu
Clinically Proven Treatment for Safe Weight Management
Compounded Semaglutide and Tirzepatide are available as injections or oral drops, delivered directly to your doorstep. It has the same active ingredients as the branded drugs.
AVYIA offers free Telehealth consultations, and if you qualify, the session can be converted into a full medical appointment for prescription. See details below:
To be eligible, you must have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related medical condition.
Compounded Semaglutide or Tirzepatide contains the same active GLP-1 ingredient. Qualified patients will be prescribed the medication, and our licensed provider will offer step-by-step instructions on how to titrate the medication and administer it to yourself.
Common side effects of compounded Semaglutide include nausea, vomiting, diarrhea, constipation, and decreased appetite. These side effects are usually mild and tend to decrease over time as your body adjusts to the medication.
A randomized, placebo-controlled study shows that, on average, participants taking:
AVYIA’s compounded weight loss program offers flexible, subscription-based pricing with the option to cancel at any time. Compound Semaglutide is priced at $99 for the first month, followed by $249 or $349 per month depending on the dosage. Similarly, compound Tirzepatide starts at $149 for the first month and transitions to $349 or $399 per month thereafter.
To make starting the program more accessible, the $149 Telehealth appointment fee is waived for subscribers, making it easier to embark on your weight loss journey.
*The medications provided are sourced from compounding pharmacies fully licensed by the State Board of Pharmacy or from FDA-licensed 503(a/b) facilities. Compounded Semaglutide and Tirzepatide are not approved or evaluated by the FDA for safety, efficacy, or quality. In contrast, Wegovy®, Ozempic®, Mounjaro®, Zepbound®, and Rybelsus® are FDA-approved for weight loss or type 2 diabetes. Weight loss studies for these branded products may not reflect the same effects of compounded medications. Consult your provider to determine if branded or off-label weight loss medication is right for you.
We offer prescription only Telehealth appointment service for Ozempic®, Wegovy® and Rybelsus® (Semaglutide) as well as Mounjaro® or Zepbound® (Tirzepatide).
AVYIA offers free Telehealth consultations, and if you qualify, the session can be converted into a full medical appointment for prescription. See details below:
To be eligible, you must have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related medical condition.
Compound Tirzepaptide the same active ingredient in Mounjaro® / Zepbound® is a once-a-week injection. If you qualify and is prescribed of the medication, then our licensed provider will provide you with a step-by-step instruction on how to properly inject.
Common side effects of Tirzepaptide include nausea, vomiting, diarrhea, constipation, and decreased appetite. These side effects are usually mild and tend to decrease over time as your body adjusts to the medication.
A randomized, placebo-controlled study shows that, on average, participants taking:
*For prescription-only Telehealth appointment services, your medical provider will conduct a comprehensive medical evaluation and, if you qualify, prescribe the name-brand GLP-1 medication to you. The $149 fee can be waived if you subscribe to the AVYIA compounded weight loss program for a minimum commitment of three months.
*The medications provided are sourced from compounding pharmacies fully licensed by the State Board of Pharmacy or from FDA-licensed 503(a/b) facilities. Compounded Semaglutide and Tirzepatide are not approved or evaluated by the FDA for safety, efficacy, or quality. In contrast, Wegovy®, Ozempic®, Mounjaro®, Zepbound®, and Rybelsus® are FDA-approved for weight loss or type 2 diabetes. Weight loss studies for these branded products may not reflect the same effects of compounded medications. Consult your provider to determine if branded or off-label weight loss medication is right for you.
The latest weight loss injections can jumpstart metabolic processes by mimicking a naturally occurring hormone in your body. The medication enhances the body’s ability to suppress appetite and slows down digestion, which tells your brain to feel fuller longer.
Semaglutide found in Ozempic® and Wegovy® is the first class of groundbreaking medication that has been shown to significantly aid in losing weight and long-term use. Here’s an in-depth look at how Semaglutide functions and its effects on your body to promote weight loss:
Mimics both GLP-1 and GIP hormones (dual action), further enhancing appetite control and insulin response.
Dual action more effectively reduces hunger and boosts satiety, potentially leading to greater calorie reduction and easier long-term adherence.
Also slows gastric emptying, with enhanced effects on satiety and appetite control due to GIP action.
More effectively enhances insulin sensitivity, promoting better blood sugar management and potentially greater reductions in fat storage.
Further reduces glucagon levels, contributing to even better blood sugar stability and possibly enhanced weight loss benefits.
Dual hormone action more significantly increases fat utilization, helping the body burn fat more effectively.
Potentially stronger metabolic rate increase due to dual-hormone influence, resulting in greater calorie burn and energy expenditure.
Semaglutide and Tirzepaptide are FDA-approved medication that has gained significant public attention for its effectiveness in aiding weight loss. While these medications are effective, it is important to be aware of potential side effects, which can include nausea, diarrhea, vomiting, and constipation, particularly during the initial stages of treatment. Most side effects, however, tend to decrease as the body adjusts to the medication.
Body Mass Index (BMI) is a critical factor in determining eligibility for Semaglutide as a weight loss treatment. BMI is a simple calculation that assesses whether an individual’s weight is appropriate for their height.
BMI of 30 or higher qualifies an individual as obese, by definition.
BMI of 27 or higher with weight-related health conditions (e.g., Type 2 diabetes, high blood pressure, high cholesterol) may also qualify someone for GLP-1 medications.
Using Semaglutide injections effectively requires following the prescribed guidelines closely. This injectable medication is designed to assist in weight loss by reducing appetite and controlling blood sugar levels. Below are key steps for correct usage:
AVYIA’s weight loss injections offer numerous benefits in addition to simply lose weight, individuals struggling with obesity or overweight conditions that include the following:
AVYIA makes it easy and convenient to start your journey. Here’s a 1-2-3 guide on how to get prescription for both name brands or compounded weight loss medications:
AVYIA provides continuous support, refills and monitoring your dosages to help you achieve the best possible results. This includes follow-up consultations to assess your progress, adjust your dosages, and provide guidance on diet, exercise, and healthy lifestyle changes if necessary.
